Cargando…
Reductions in COQ2 Expression Relate to Reduced ATP Levels in Multiple System Atrophy Brain
Multiple system atrophy (MSA) is a progressive neurodegenerative disease clinically characterized by parkinsonism and cerebellar ataxia, and pathologically by oligodendrocyte α-synuclein inclusions. Genetic variants of COQ2 are associated with an increased risk for MSA in certain populations. Also,...
Autores principales: | Hsiao, Jen-Hsiang T., Purushothuman, Sivaraman, Jensen, Poul H., Halliday, Glenda M., Kim, Woojin Scott |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838639/ https://www.ncbi.nlm.nih.gov/pubmed/31736705 http://dx.doi.org/10.3389/fnins.2019.01187 |
Ejemplares similares
-
Cross-examining candidate genes implicated in multiple system atrophy
por: Katzeff, Jared S., et al.
Publicado: (2019) -
Altered lipid levels provide evidence for myelin dysfunction in multiple system atrophy
por: Don, Anthony S, et al.
Publicado: (2014) -
Role of Oligodendrocyte Lineage Cells in Multiple System Atrophy
por: Hsiao, Jen-Hsiang T., et al.
Publicado: (2023) -
Animal modeling an oligodendrogliopathy – multiple system atrophy
por: Bleasel, Jonathan M., et al.
Publicado: (2016) -
Exploring Myelin Dysfunction in Multiple System Atrophy
por: Wong, Joanna H., et al.
Publicado: (2014)